COVID-19 vaccine support items coming to an end From 1 July, the MBS items for vaccine suitability assessments, and associated items, introduced during the pandemic, will cease.
TGA warns of ‘possible but rare’ RSV vaccines risk Product Information for Arexvy and Abrysvo has been updated to reflect a low risk of Guillain-Barre Syndrome following vaccination.
Why doesn’t Australia make more medicines? Medicine shortages in Australia are not new. So, could we prevent medication shortages if Australia made more medicines?
Chronic Wound Consumables Scheme finally on the way Launching in May, the long-awaited scheme covers the cost of products including bandages and dressings for eligible patients with diabetes.
GPs remain the frontline in vaccination With the WHO warning global immunisation gains are at risk, an RACGP expert says GPs are best placed to get vaccination rates up.
Study examines whether RSV vaccine lasts ‘at least three winters’ The results of a randomised controlled trial indicate an RSV vaccine could offer protection against the virus over three seasons in over 60s.
Diabetes prevalence underestimated in Australia: Study Researchers have suggested the number of people living with diabetes could be more than a third higher than officially registered.
RACGP calls for action as flu cases reach record high With cases skyrocketing to almost 50,000 in 2025, the college is calling on GPs and the community to ‘work together and get vaccinated’.
Study suggests answer to reducing RSV hospital admissions Research evaluating the effectiveness of RSV vaccination among babies in WA has found a significant reduction in hospital admissions.
What’s in the 2025–26 Federal Budget for GPs? The RACGP has welcomed GP workforce incentives but said while ‘it’s clear general practice is central in this year’s Budget’, there are still missed opportunities.